Drug profile · INN
dolasetron mesylate
ANZEMET
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dolasetron mesylate (ANZEMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN dolasetron mesylate
Brand ANZEMET
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is dolasetron mesylate?
dolasetron mesylate (ANZEMET) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dolasetron mesylate?
ANZEMET is a marketed brand name for dolasetron mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dolasetron mesylate?
dolasetron mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.